N-(5-Bromo-4-ethylthiazol-2-yl)acetamide

Introduction

CAS No. :	1267904-60-8	MDL No. :	MFCD12756845
Formula :	C7H9BrN2OS	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	LODCKIISMKDQFH-UHFFFAOYSA-N
M.W :	249.13	Pubchem ID :	54759077
Synonyms :

Physicochemical Properties

Num. heavy atoms :	12
Num. arom. heavy atoms :	5
Fraction Csp3 :	0.43
Num. rotatable bonds :	3
Num. H-bond acceptors :	2.0
Num. H-bond donors :	1.0
Molar Refractivity :	53.9
TPSA :	70.23 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.17 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.75
Log Po/w (XLOGP3) :	2.32
Log Po/w (WLOGP) :	2.24
Log Po/w (MLOGP) :	0.73
Log Po/w (SILICOS-IT) :	3.02
Consensus Log Po/w :	2.01

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.96
Solubility :	0.275 mg/ml ; 0.00111 mol/l
Class :	Soluble
Log S (Ali) :	-3.43
Solubility :	0.0918 mg/ml ; 0.000369 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-3.33
Solubility :	0.116 mg/ml ; 0.000466 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.74

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine